Literature DB >> 6176753

[Side-effects of polychemotherapy in metastatic testicular neoplasms (author's transl)].

J H Hartlapp, N Jaeger, P Fischer, L Weissbach.   

Abstract

25 Patients with metastatic non-seminomatous testicular neoplasms were treated by surgery and cytostatic therapy using a combination consisting of Velban, Bleomycin, Cis-Platinum and/or Ifosfamid. In 22 patients this procedure induced a persistant complete remission with a mean observation time of 23 months. 2 patients died because of post-surgical complications after a second-look-lymphadenectomy. They suffered from rapidly progressive tumor disease. One patient died in a septicemia during chemotherapy. Our experience is that morbidity of an effective chemotherapy should not be underestimated. Transient bone marrow suppression, anorexia, alopecia and hyperpigmentation are unavoidable. However, severe vomiting, disturbed electrolyte metabolism, hemorrhagic cystitis, anemia and septicemia can well be managed by respective supportive care. Septicemia, for instance, may be treated with appropriate antibiotics without inducing tubular necrosis. Supportive measures also will avoid severe chronic defects of ear and kidney function.

Entities:  

Mesh:

Substances:

Year:  1982        PMID: 6176753     DOI: 10.1007/BF01728345

Source DB:  PubMed          Journal:  Klin Wochenschr        ISSN: 0023-2173


  17 in total

Review 1.  [What has been achieved in the therapy of malignant testicular tumors?].

Authors:  C Gropp; M Schmidt; K Havemann
Journal:  Internist (Berl)       Date:  1979-12       Impact factor: 0.743

2.  Vinblastine (NSC-49842) and bleomycin (NSC-125066) therapy for disseminated testicular tumors.

Authors:  S C Spigel; C A Coltman
Journal:  Cancer Chemother Rep       Date:  1974 Mar-Apr

3.  Clinical use of adriamycin in advanced testicular cancer.

Authors:  S Monfardini; E Bajetta; R Musumeci; G Bonadonna
Journal:  J Urol       Date:  1972-08       Impact factor: 7.450

4.  Combination chemotherapy in disseminated testicular cancer: the Indiana University experience.

Authors:  L H Einhorn; J P Donohue
Journal:  Semin Oncol       Date:  1979-03       Impact factor: 4.929

5.  [Second-look operations in urology with special regard to testicular neoplasms].

Authors:  L Weissbach; N Jaeger; J Hartlapp
Journal:  MMW Munch Med Wochenschr       Date:  1980-05-02

6.  Continuous intravenous bleomycin (NSC-125066) therapy with vinblastine (NSC-49842) in stage III testicular neoplasia.

Authors:  M L Samuels; D E Johnson; P Y Holoye
Journal:  Cancer Chemother Rep       Date:  1975 May-Jun

7.  Combination radical surgery and multiple sequential chemotherapy for the treatment of advanced carcinoma of the testis (stage III).

Authors:  C Merrin; H Takita; R Weber; Z Wajsman; G Baumgartner; G P Murphy
Journal:  Cancer       Date:  1976-01       Impact factor: 6.860

8.  Acute renal failure associated with combined gentamicin and cephalothin therapy.

Authors:  J P Fillastre; R Laumonier; G Humbert; D Dubois; J Metayer; A Delpech; J Leroy; M Robert
Journal:  Br Med J       Date:  1973-05-19

9.  Combined management of malignant teratoma of the testis.

Authors:  M J Peckham; T J McElwain; A Barrett; W F Hendry
Journal:  Lancet       Date:  1979-08-11       Impact factor: 79.321

10.  Cis-diamminedichloroplatinum, vinblastine, and bleomycin combination chemotherapy in disseminated testicular cancer.

Authors:  L H Einhorn; J Donohue
Journal:  Ann Intern Med       Date:  1977-09       Impact factor: 25.391

View more
  1 in total

1.  Antimicrobial prophylaxis in immunocompromised patients.

Authors:  J H Hartlapp
Journal:  Drugs       Date:  1987       Impact factor: 9.546

  1 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.